Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caris Life Sciences (CAI) Retained Earnings (2024 - 2025)

Caris Life Sciences (CAI) has 2 years of Retained Earnings data on record, last reported at $936000.0 in Q4 2025.

  • For Q4 2025, Retained Earnings rose 100.04% year-over-year to $936000.0; the TTM value through Dec 2025 reached $936000.0, up 100.04%, while the annual FY2025 figure was $936000.0, 100.04% up from the prior year.
  • Retained Earnings reached $936000.0 in Q4 2025 per CAI's latest filing, up from -$2.6 billion in the prior quarter.
  • Across five years, Retained Earnings topped out at $936000.0 in Q4 2025 and bottomed at -$2.6 billion in Q3 2025.